Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: SICAV
  • Objective: European Region
  • Asset Class: Equity
  • Geographic Focus: European Region

JPMorgan Funds - Europe Research Enhanced Index Equity Fund

+ Add to Watchlist

JPEREIX:LX

188.44 EUR 1.77 0.95%

As of 00:59:30 ET on 02/26/2015.

Snapshot for JPMorgan Funds - Europe Research Enhanced Index Equity Fund (JPEREIX)

Year To Date: +13.89% 3-Month: +12.56% 3-Year: +17.18% 52-Week Range: 148.55 - 188.44
1-Month: +4.79% 1-Year: +19.33% 5-Year: - Beta vs LUXXX: 0.81

Mutual Fund Chart for JPEREIX

No chart data available.
  • JPEREIX:LX 188.44
  • 1M
  • 1Y
Interactive JPEREIX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for JPEREIX

JPMorgan Funds - Europe Research Enhanced Index Equity Fund is a SICAV incorporated in Luxembourg. The Fund's objective is long-term return. The Fund invests at least 67% of its total assets in equity and equity-linked securities of companies that are incorporated under the laws of, and have their registered office in a European country, or derive their economic activity from Europe.

Inception Date: 09-08-2011 Telephone: 352-34-10-101 Tel
Managers: DEMETRIS GEORGHIOU / IDO EISENBERG
Web Site: www.jpmorganassetmanagement.com

Fundamentals for JPEREIX

NAV (on 2015-02-26) 188.44
Assets (M) (on 2015-02-26) 81.56
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment 0.00

Dividends for JPEREIX

No dividends reported

Fees & Expenses for JPEREIX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.00
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 0.15

Top Fund Holdings for JPEREIX

Filing Date: 01/31/2015
Name Position Value % of Total
Nestle SA 28,856 1,958,400 3.400%
Royal Dutch Shell PLC 65,292 1,728,000 3.000%
Roche Holding AG 6,253 1,497,600 2.600%
Novartis AG 17,244 1,497,600 2.600%
HSBC Holdings PLC 149,123 1,209,600 2.100%
Bayer AG 8,563 1,094,400 1.900%
British American Tobacco PLC 21,921 1,094,400 1.900%
Sanofi 12,644 1,036,800 1.800%
BP PLC 155,266 864,000 1.500%
AstraZeneca PLC 13,690 864,000 1.500%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil